Matt Miksic
Stock Analyst at Barclays
(3.18)
# 2,438
Out of 4,371 analysts
807
Total ratings
49.5%
Success rate
1.7%
Average return
Main Sectors:
Stocks Rated by Matt Miksic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintained: Buy | $96 → $89 | $47.69 | +86.62% | 50 | May 28, 2026 | |
| PODD Insulet | Maintained: Sell | $198 | $143.30 | +38.17% | 20 | May 28, 2026 | |
| DXCM DexCom | Rated: Sell | $67 → $64 | $72.77 | -12.05% | 22 | May 18, 2026 | |
| AVR Anteris Technologies Global | Maintained: Buy | $17 → $18 | $8.95 | +101.12% | 6 | May 15, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Hold | $255 | $223.24 | +14.23% | 93 | May 13, 2026 | |
| OBIO Orchestra BioMed Holdings | Rated: Buy | $12 → $13 | $3.86 | +236.79% | 7 | May 13, 2026 | |
| HUMA Humacyte | Rated: Buy | $1.5 | $1.40 | +7.14% | 4 | May 13, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $202 → $204 | $145.61 | +40.10% | 23 | May 11, 2026 | |
| GMED Globus Medical | Maintained: Buy | $123 | $77.95 | +57.79% | 49 | May 11, 2026 | |
| SENS Senseonics Holdings | Maintained: Buy | $31 | $6.72 | +361.31% | 7 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $55 | $18.03 | +205.05% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $76 | $71.33 | +6.55% | 21 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $19 | $13.49 | +40.85% | 26 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $24 | $7.68 | +212.50% | 16 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 71.16 → CHF 61.68 | $51.26 | +20.32% | 21 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $18.54 | +45.63% | 41 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $469 → $394 | $295.00 | +33.56% | 48 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $14.87 | +34.50% | 18 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $87 → $78 | $62.03 | +25.75% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $100 → $94 | $84.98 | +10.61% | 40 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $104 → $110 | $86.00 | +27.91% | 58 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $712 → $651 | $407.29 | +59.84% | 19 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $144 → $143 | $86.99 | +64.39% | 50 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $118 → $120 | $77.95 | +53.94% | 68 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $14.26 | +82.33% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 | $60.34 | +70.70% | 6 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.33 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $722 → $418 | $161.71 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $13 | $0.67 | n/a | 2 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $28 | $15.27 | n/a | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74 → $67 | $9.64 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $75.74 | n/a | 3 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $79 → $87 | $16.10 | n/a | 25 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $22.40 | n/a | 1 | Sep 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $9 | $3.61 | n/a | 1 | Dec 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $2.26 | n/a | 1 | Oct 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 | $29.93 | n/a | 1 | Nov 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 | $8.21 | n/a | 2 | Oct 10, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $33 → $36 | $33.06 | n/a | 2 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 | $9.72 | n/a | 3 | Mar 14, 2013 |
Boston Scientific
May 28, 2026
Maintained: Buy
Price Target: $96 → $89
Current: $47.69
Upside: +86.62%
Insulet
May 28, 2026
Maintained: Sell
Price Target: $198
Current: $143.30
Upside: +38.17%
DexCom
May 18, 2026
Rated: Sell
Price Target: $67 → $64
Current: $72.77
Upside: -12.05%
Anteris Technologies Global
May 15, 2026
Maintained: Buy
Price Target: $17 → $18
Current: $8.95
Upside: +101.12%
Johnson & Johnson
May 13, 2026
Reiterated: Hold
Price Target: $255
Current: $223.24
Upside: +14.23%
Orchestra BioMed Holdings
May 13, 2026
Rated: Buy
Price Target: $12 → $13
Current: $3.86
Upside: +236.79%
Humacyte
May 13, 2026
Rated: Buy
Price Target: $1.5
Current: $1.40
Upside: +7.14%
Becton, Dickinson and Company
May 11, 2026
Rated: Buy
Price Target: $202 → $204
Current: $145.61
Upside: +40.10%
Globus Medical
May 11, 2026
Maintained: Buy
Price Target: $123
Current: $77.95
Upside: +57.79%
Senseonics Holdings
May 11, 2026
Maintained: Buy
Price Target: $31
Current: $6.72
Upside: +361.31%
May 8, 2026
Maintained: Buy
Price Target: $56 → $55
Current: $18.03
Upside: +205.05%
May 7, 2026
Maintained: Hold
Price Target: $73 → $76
Current: $71.33
Upside: +6.55%
May 7, 2026
Maintained: Buy
Price Target: $21 → $19
Current: $13.49
Upside: +40.85%
May 6, 2026
Maintained: Buy
Price Target: $27 → $24
Current: $7.68
Upside: +212.50%
May 6, 2026
Reiterated: Hold
Price Target: CHF 71.16 → CHF 61.68
Current: $51.26
Upside: +20.32%
May 4, 2026
Maintained: Buy
Price Target: $25 → $27
Current: $18.54
Upside: +45.63%
May 1, 2026
Maintained: Buy
Price Target: $469 → $394
Current: $295.00
Upside: +33.56%
Apr 30, 2026
Maintained: Hold
Price Target: $20
Current: $14.87
Upside: +34.50%
Apr 30, 2026
Maintained: Hold
Price Target: $87 → $78
Current: $62.03
Upside: +25.75%
Apr 29, 2026
Maintained: Sell
Price Target: $100 → $94
Current: $84.98
Upside: +10.61%
Apr 24, 2026
Maintained: Buy
Price Target: $104 → $110
Current: $86.00
Upside: +27.91%
Apr 23, 2026
Rated: Buy
Price Target: $712 → $651
Current: $407.29
Upside: +59.84%
Apr 20, 2026
Rated: Buy
Price Target: $144 → $143
Current: $86.99
Upside: +64.39%
Apr 1, 2026
Maintained: Buy
Price Target: $118 → $120
Current: $77.95
Upside: +53.94%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $14.26
Upside: +82.33%
Mar 24, 2026
Reiterated: Buy
Price Target: $103
Current: $60.34
Upside: +70.70%
May 11, 2022
Reiterated: Buy
Price Target: $25
Current: $2.33
Upside: n/a
May 4, 2022
Maintained: Buy
Price Target: $722 → $418
Current: $161.71
Upside: n/a
Mar 4, 2022
Maintained: Buy
Price Target: $16 → $13
Current: $0.67
Upside: n/a
Mar 2, 2022
Maintained: Buy
Price Target: $31 → $28
Current: $15.27
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $74 → $67
Current: $9.64
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $100
Current: $75.74
Upside: n/a
Nov 3, 2021
Maintained: Buy
Price Target: $79 → $87
Current: $16.10
Upside: n/a
Sep 30, 2021
Initiated Coverage: Buy
Price Target: $55
Current: $22.40
Upside: n/a
Dec 12, 2016
Initiated Coverage: Sell
Price Target: $9
Current: $3.61
Upside: n/a
Oct 31, 2016
Initiated Coverage: Buy
Price Target: $21
Current: $2.26
Upside: n/a
Nov 3, 2014
Maintained: Hold
Price Target: $37
Current: $29.93
Upside: n/a
Oct 10, 2013
Downgraded: Hold
Price Target: $30
Current: $8.21
Upside: n/a
Jul 24, 2013
Rated: Hold
Price Target: $33 → $36
Current: $33.06
Upside: n/a
Mar 14, 2013
Reiterated: Hold
Price Target: $43
Current: $9.72
Upside: n/a